๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Optimization of ultrafilter feed conditions using classical filtration models

โœ Scribed by J.G.H. Geeting; R.T. Hallen; R.A. Peterson


Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
237 KB
Volume
265
Category
Article
ISSN
0376-7388

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


The use of optimized tunneling paths wit
โœ Enric Bosch; Miquel Moreno; Josรฉ M. Lluch ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 368 KB

A semi-classical tunneling methodology combined with the use of classical trajectories is adopted in order to evaluate the tunneling splittings for bi-dirnensional surfaces of malonaldehyde and hydrogenoxalate anion proton transfer reactions. It is shown that the optimization of the tunneling path m

Protein purification using chromatograph
โœ J. A. Asenjo; B. A. Andrews ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 510 KB

## Abstract To achieve a high level of purity in the purification of recombinant proteins for therapeutic or analytical application, it is necessary to use several chromatographic steps. There is a range of techniques available including anion and cation exchange, which can be carried out at differ

Retention modeling and simultaneous opti
โœ Yichu Shan; Ruihuan Zhao; Yukui Zhang; Weibing Zhang; Yan Tian ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 436 KB

## Abstract A novel approach is proposed for the simultaneous optimization of mobile phase pH and gradient steepness in RPโ€HPLC using artificial neural networks. By presetting the initial and final concentration of the organic solvent, a limited number of experiments with different gradient time an

Optimal drug pricing, limited use condit
โœ Gregory S. Zaric ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 210 KB

## Abstract Limited use conditions (LUCs) are a method of directing treatment with new drugs to those populations where they will be most cost effective. In this paper we investigate how a drug manufacturer could determine pricing and LUCs to maximize profits. We assume that the payer makes formula